Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03701763. IPD Sharing: YES. Countries: 10. Publications: 1.
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
ClinicalTrials.gov study NCT03559517. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
ClinicalTrials.gov study NCT05272150. IPD Sharing: YES. Countries: 2. Publications: 3.
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
ClinicalTrials.gov study NCT00603746. IPD Sharing: YES. Countries: 16. Publications: 2.
Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00708552. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
ClinicalTrials.gov study NCT04713592. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT04040192. IPD Sharing: YES. Countries: 6. Publications: 2.
A Study of Semorinemab in Patients With Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT03828747. IPD Sharing: YES. Countries: 4. Publications: 3.
Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT04023396. IPD Sharing: NO. Countries: 16. Publications: 2.
PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01350128. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
ClinicalTrials.gov study NCT03281538. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT00408629. IPD Sharing: Not stated. Countries: 18. Publications: 4.
A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
ClinicalTrials.gov study NCT00771667. IPD Sharing: Not stated. Countries: 12. Publications: 4.
Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)
ClinicalTrials.gov study NCT02465567. IPD Sharing: Not stated. Countries: 26. Publications: 5.
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT00363896. IPD Sharing: Not stated. Countries: 16. Publications: 1.
A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne
ClinicalTrials.gov study NCT03450369. IPD Sharing: NO. Countries: 1. Publications: 28.
A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
ClinicalTrials.gov study NCT01369355. IPD Sharing: Not stated. Countries: 26. Publications: 16.
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
ClinicalTrials.gov study NCT03160885. IPD Sharing: NO. Countries: 9. Publications: 7.
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT04033445. IPD Sharing: YES. Countries: 34. Publications: 3.
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
ClinicalTrials.gov study NCT04871711. IPD Sharing: NO. Countries: 6. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.